Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2

Nature Communications

Volumn 7, Issue , 2016, Pages

  El Karoui, Khalil ^a,b   Viau, Amandine ^a   Dellis, Olivier ^c   Bagattin, Alessia ^d   Nguyen, Clément ^a   Baron, William ^a   Burtin, Martine ^a   Broueilh, Mélanie ^a   Heidet, Laurence ^e   Mollet, Géraldine ^e   Druilhe, Anne ^a   Antignac, Corinne ^e   Knebelmann, Bertrand ^a   Friedlander, Gérard ^a,b   Bienaimé, Frank ^a,b   Gallazzini, Morgan ^a   Terzi, Fabiola ^a  

^a INSTITUT NECKER ENFANTS MALADES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c INSERM   (France)

^d INSTITUT COCHIN   (France)

^e IMAGINE INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; ACTIVATING TRANSCRIPTION FACTOR 4; ALBUMIN; CALCIUM; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; ALBUMINOID; LCN2 PROTEIN, MOUSE; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; PODOCIN; SIGNAL PEPTIDE; WT1 PROTEIN;

APOPTOSIS; CALCIUM; CELL ORGANELLE; GENE EXPRESSION; INHIBITOR; MORTALITY; PROTEIN; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE INACTIVATION; GENE OVEREXPRESSION; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE CELL; MORTALITY; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEINURIA; UNFOLDED PROTEIN RESPONSE; ANIMAL; COMPLICATION; DRUG EFFECTS; EXON; GENETICS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MALE; METABOLISM; MUTANT MOUSE STRAIN; PHYSIOLOGY;

MUS;

ACUTE-PHASE PROTEINS; ALBUMINS; ANIMALS; ENDOPLASMIC RETICULUM STRESS; EXONS; FEMALE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY DISEASES; LIPOCALIN-2; LIPOCALINS; MALE; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; ONCOGENE PROTEINS; PROTEINURIA; UNFOLDED PROTEIN RESPONSE; WT1 PROTEINS;

EID: 84955576959     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10330     Document Type: Article

References (52)

1. Radhakrishnan, J. et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. Kidney Int. 86, 246-250 (2014).
2. Remuzzi, G., Benigni, A. & Remuzzi, A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J. Clin. Invest. 116, 288-296 (2006).
3. Cravedi, P., Ruggenenti, P. & Remuzzi, G. Proteinuria should be used as a surrogate in CKD. Nat. Rev. Nephrol. 8, 301-306 (2012).
4. Gross, M. L. et al. Intraperitoneal protein injection in the axolotl: the amphibian kidney as a novel model to study tubulointerstitial activation. Kidney Int. 62, 51-59 (2002).
5. Zandi-Nejad, K., Eddy, A. A., Glassock, R. J. & Brenner, B. M. Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int. Suppl. S76-S89 (2004).
6. Ruggenenti, P., Cravedi, P. & Remuzzi, G. Mechanisms and treatment of CKD. J. Am. Soc. Nephrol. 23, 1917-1928 (2012).
7. Risdon, R. A., Sloper, J. C. & De Wardener, H. E. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2, 363-366 (1968).
8. Abbate, M., Zoja, C. & Remuzzi, G. How does proteinuria cause progressive renal damage? J. Am. Soc. Nephrol. 17, 2974-2984 (2006).
9. Perico, N., Benigni, A. & Remuzzi, G. Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat. Rev. Drug Discov. 7, 936-953 (2008).
10. Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861-869 (2001).
11. Ruggenenti, P., Perna, A. & Remuzzi, G. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int. 63, 2254-2261 (2003).
12. Eijkelkamp, W. B. et al. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J. Am. Soc. Nephrol. 18, 1540-1546 (2007).
13. Parving, H. H. et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N. Engl. J. Med. 367, 2204-2213 (2012).
14. Walter, P. & Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081-1086 (2011).
15. Hetz, C., Chevet, E. & Harding, H. P. Targeting the unfolded protein response in disease. Nat. Rev. Drug Discov. 12, 703-719 (2013).
16. Ohse, T. et al. Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells. Kidney Int. 70, 1447-1455 (2006).
17. Lindenmeyer, M. T. et al. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. J. Am. Soc. Nephrol. 19, 2225-2236 (2008).
18. Wu, X., He, Y., Jing, Y., Li, K. & Zhang, J. Albumin overload induces apoptosis in renal tubular epithelial cells through a CHOP-dependent pathway. OMICS 14, 61-73 (2010).
19. Ratelade, J. et al. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes. Hum. Mol. Genet. 19, 1-15 (2010).
20. Mollet, G. et al. Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome. J. Am. Soc. Nephrol. 20, 2181-2189 (2009).
21. Pippin, J. W. et al. Inducible rodent models of acquired podocyte diseases. Am. J. Physiol. Renal Physiol. 296, F213-F229 (2009).
22. Tang, S. et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J. Clin. Invest. 111, 515-527 2003
23. Lee, Y. J. & Han, H. J. Albumin-stimulated DNA synthesis is mediated by Ca2/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-kappaB signal pathways in renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 294, F534-F541 (2008).
24. Sweeney, Z. K., Minatti, A., Button, D. C. & Patrick, S. Small-molecule inhibitors of store-operated calcium entry. ChemMedChem 4, 706-718 2009
25. Mahadevan, N. R. et al. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-kappaB-dependent manner. BMC Cancer 11, 229 (2011).
26. Viau, A. et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J. Clin. Invest. 120, 4065-4076 (2010).
27. Erkan, E., De Leon, M. & Devarajan, P. Albumin overload induces apoptosis in LLC-PK(1) cells. Am. J. Physiol. Renal Physiol. 280, F1107-F1114 (2001).
28. Tabas, I. & Ron, D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13, 184-190 (2011).
29. Chakraborty, S., Kaur, S., Guha, S. & Batra, S. K. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim. Biophys. Acta 1826, 129-169 (2012).
30. Erkan, E. et al. Induction of renal tubular cell apoptosis in focal segmental glomerulosclerosis: roles of proteinuria and Fas-dependent pathways. J. Am. Soc. Nephrol. 16, 398-407 (2005).
31. Han, J. et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol. 15, 481-490 (2013).
32. Maestri, N. E., Brusilow, S. W., Clissold, D. B. & Bassett, S. S. Long-term treatment of girls with ornithine transcarbamylase deficiency. N. Engl. J. Med. 335, 855-859 (1996).
33. Chen, S. et al. Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytes. Cell Calcium 50, 523-529 (2011).
34. Rampino, T. et al. KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cells. Growth Factors 25, 382-391 (2007).
35. Gburek, J. et al. Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J. Am. Soc. Nephrol. 13, 423-430 (2002).
36. Cui, S., Verroust, P. J., Moestrup, S. K. & Christensen, E. I. Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am. J. Physiol. 271, F900-F907 (1996).
37. Hsin, I. L. et al. Lipocalin 2, a new GADD153 target gene, as an apoptosis inducer of endoplasmic reticulum stress in lung cancer cells. Toxicol. Appl. Pharmacol. 263, 330-337 (2012).
38. Devireddy, L. R., Gazin, C., Zhu, X. & Green, M. R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123, 1293-1305 (2005).
39. Liu, Z. et al. Multiple apoptotic defects in hematopoietic cells from mice lacking lipocalin 24p3. J. Biol. Chem. 286, 20606-20614 (2011).
40. Kagoya, Y. et al. JAK2V617F myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2. Blood 124, 2996-3006 (2014).
41. Bao, G. et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat. Chem. Biol. 6, 602-609 (2010).
42. Satoh, T. et al. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J. Neurochem. 104, 1116-1131 (2008).
43. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296-1305 (2004).
44. Liu, S. K., Yan, C., Wu, L. L. & Pan, Y. [Study strategies for neurobiology mechanism of 'kidney storing will and responding to fear']. Zhong. Xi. Yi. Jie. He. Xue. Bao. 8, 106-110 (2010).
45. Liu, K. D. et al. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int. 83, 909-914 (2013).
46. Bolignano, D. et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol. Dial. Transplant. 23, 414-416 (2008).
47. Smyth, L. J., Duffy, S., Maxwell, A. P. & McKnight, A. J. Genetic and epigenetic factors influencing chronic kidney disease. Am. J. Physiol. Renal. Physiol. 307, F757-F776 (2014).
48. Ozcan, U. et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140 (2006).
49. Runembert, I. et al. Vimentin affects localization and activity of sodium-glucose cotransporter SGLT1 in membrane rafts. J. Cell. Sci. 115, 713-724 (2002).
50. Sison, K. et al. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J. Am. Soc. Nephrol. 21, 1691-1701 (2010).
51. Mizuno, S. et al. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 101, 1827-1834 (1998).
52. Vandesompele, J. et al. Accurate normalization of real-time quantitative RTPCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034 (2002).